Epidermal growth factor receptor (EGFR) is often overexpressed or mutated in a variety of cancers, like lung cancer and colorectal cancer [13, 14], and this leads to enhanced activation and tumorigenesis. This evidence concerns the gene EGFR and lung cancer.